Differential antitumor immunity mediated by NKT cell subsets in vivo

Journal of Experimental Medicine

Volumn 202, Issue 9, 2005, Pages 1279-1288

  Crowe, Nadine Y ^a   Coquet, Jonathan M ^a   Berzins, Stuart P ^a   Kyparissoudis, Konstantinos ^a   Keating, Rachael ^a   Pellicci, Daniel G ^a   Hayakawa, Yoshihiro ^b   Godfrey, Dale I ^a   Smyth, Mark J ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; ALPHA GALACTOSYLCERAMIDE; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; IMMUNE DEFICIENCY; LIVER; MELANOMA B16; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL; SPLEEN; THYMUS; TUMOR IMMUNITY;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD4; CELL LINE, TUMOR; GALACTOSYLCERAMIDES; IMMUNITY, CELLULAR; INTERLEUKIN-4; KILLER CELLS, NATURAL; LIVER; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SARCOMA, EXPERIMENTAL; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 27744562232     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20050953     Document Type: Article

References (49)

1. Godfrey, D.I., H.R. MacDonald, M. Kronenberg, M.J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4:231-237.
2. Hayakawa, Y., D.I. Godfrey, and M.J. Smyth. 2004. Alpha- galactosylceramide: potential immunomodulatory activity and future application. Curr. Med. Chem. 11:241-252.
3. Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y.P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science. 306:1786-1789.
4. Mattner, J., K.L. Debord, N. Ismail, R.D. Goff, C. Cantu III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature. 434:525-529.
5. Kinjo, Y., D. Wu, G. Kim, G.W. Xing, M.A. Poles, D.D. Ho, M. Tsuji, K. Kawahara, C.H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature. 434:520-525.
6. Wu, D., G.W. Xing, M.A. Poles, A. Horowitz, Y. Kinjo, B. Sullivan, V. Bodmer-Narkevitch, O. Plettenburg, M. Kronenberg, M. Tsuji, et al. 2005. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc. Natl. Acad. Sci. USA. 102:1351-1356.
7. Sriram, V., W. Du, J. Gervay-Hague, and R.R. Brutkiewicz. 2005. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1dspecific ligands for NKT cells. Eur. J. Immunol. 35:1692-1701.
8. Fischer, K., E. Scotet, M. Niemeyer, H. Koebernick, J. Zerrahn, S. Maillet, R. Hurwitz, M. Kursar, M. Bonneville, S.H. Kaufmann, and U.E. Schaible. 2004. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci USA.101:10685-10690.
9. Rauch, J., J. Gumperz, C. Robinson, M. Skold, C. Roy, D.C. Young, M. Lafleur, D.B. Moody, M.B. Brenner, C.E. Costello, and S.M. Behar. 2003. Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell. J Biol Chem. 278:47508-47515.
10. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for V(Alpha)14 Nkt Cells in Il-12-Mediated Rejection of Tumors. Science. 278:1623-1626.
11. Chen, Y.H., N.M. Chiu, M. Mandal, N. Wang, and C.R. Wang. 1997. Impaired NK1 T cell development and early IL-4 production in CD1-deficient mice. Immunity. 6:459-467.
12. Mendiratta, S.K., W.D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity. 6:469-477.
13. Smiley, S.T., M.H. Kaplan, and M.J. Grusby. 1997. Immunoglobulin E production in the absence of interleukin-4-secreting Cd1-dependent cells. Science. 275:977-979.
14. Eberl, G., R. Lees, S.T. Smiley, M. Taniguchi, M.J. Grusby, and H.R. MacDonald. 1999. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 162:6410-6419.
15. Hammond, K.J.L., S.B. Pelikan, N.Y. Crowe, E. Randle-Barrett, T. Nakayama, M. Taniguchi, M.J. Smyth, I.R. van Driel, R. Scollay, A.G. Baxter, and D.I. Godfrey. 1999. NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 29:3768-3781.
16. Matsuda, J.L., O.V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C.R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741-753.
17. Hammond, K.J.L., D.G. Pellicci, L.D. Poulton, O.V. Naidenko, A.A. Scalzo, A.G. Baxter, and D.I. Godfrey. 2001. CD1d-restricted NKT cells: an interstrain comparison. J. Immunol. 167:1164-1173.
18. Godfrey, D.I., and M. Kronenberg. 2004. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114:1379-1388.
19. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23:877-900.
20. Brigl, M., and M.B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22:817-890.
21. Wilson, S.B., and T.L. Delovitch. 2003. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol. 3:211-222.
22. Smyth, M.J., N.Y. Crowe, Y. Hayakawa, K. Takeda, H. Yagita, and D.I. Godfrey. 2002. NKT cells-conductors of tumor immunity? Curr. Opin. Immunol. 14:165-171.
23. Smyth, M.J., K.Y.T. Thia, S.E.A. Street, E. Cretney, J.A. Trapani, M. Taniguchi, T. Kawano, S.B. Pelikan, N.Y. Crowe, and D.I. Godfrey. 2000. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191:661-668.
24. Crowe, N.Y., M.J. Smyth, and D.I. Godfrey. 2002. A critical role for natural killer T cells in immunosurveillance of methylcholanthreneinduced sarcomas. J. Exp. Med. 196:119-127.
25. Smyth, M.J., N.Y. Crowe, D.G. Pellicci, K. Kyparissoudis, J.M. Kelly, K. Takeda, H. Yagita, and D.I. Godfrey. 2002. Sequential production of interferon-gamma by NK1.1( ) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood. 99:1259-1266.
26. Yang, Y., A. Ueno, M. Bao, Z. Wang, J.S. Im, S. Porcelli, and J.W. Yoon. 2003. Control of NKT cell differentiation by tissue-specific microenvironments. J. Immunol. 171:5913-5920.
27. Lee, P.T., K. Benlagha, L. Teyton, and A. Bendelac. 2002. Distinct functional lineages of human V alpha-24 natural killer T cells. J. Exp. Med. 195:637-641.
28. Gumperz, J.E., S. Miyake, T. Yamamura, and M.B. Brenner. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195:625-636.
29. Bollyky, P.L., and S.B. Wilson. 2004. CD1d-restricted T-cell subsets and dendritic cell function in autoimmunity. Immunol. Cell Biol. 82: 307-314.
30. Rogers, P.R., A. Matsumoto, O. Naidenko, M. Kronenberg, T. Mikayama, and S. Kato. 2004. Expansion of human Valpha24( ) NKT cells by repeated stimulation with KRN7000. J. Immunol. Methods. 285:197-214.
31. Matsuda, J.L., L. Gapin, S. Sidobre, W.C. Kieper, J.Y.T. Tan, R. Ceredig, C.D. Surh, and M. Kronenberg. 2002. Homeostasis of V(alpha) 14i NKT cells. Nat. Immunol. 3:966-974.
32. Pellicci, D.G., A.P. Uldrich, K. Kyparissoudis, N.Y. Crowe, A.G. Brooks, K.J. Hammond, S. Sidobre, M. Kronenberg, M.J. Smyth, and D.I. Godfrey. 2003. Intrathymic NKT cell development is blocked by the presence of alpha-galactosylceramide. Eur. J. Immunol. 33:1816-1823.
33. Nishigori, C., D. Yarosh, A. O'Connor, V. Shreedhar, S.E. Ullrich, P. Cox, and M. Kripke. 1998. HindIII liposomes suppress DTH responses in vivo and induce epidermal IL-10 in vitro. J. Immunol. 161:2684-2691.
34. Hunter, M., A. Wang, C. Hirota, and D. McKay. 2005. Neutralizing anti-IL10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. J. Immunol. 174:7368-7375.
35. Gorczynski, R., Z. Chen, H. Zeng, and X. Ming Fu. 1997. Specificity for in vivo graft prolongation in gd TCR hybridomas derived from mice given portal vein donor specific preimmunization and skin allografts. J. Immunol. 159:3698-3706.
36. - T cells produce IL-4. J. Immunol. 149:1211-1215.
37. Arase, H., N. Arase, K. Nakagawa, R.A. Good, and K. Onoe. 1993. NK1.1+ CD4- CD8- thymocytes with specific lymphokine secretion. Eur. J. Immunol. 23:307-310.
38. Pellicci, D.G., K.J.L. Hammond, A.P. Uldrich, A.G. Baxter, M.J. Smyth, and D.I. Godfrey. 2002. A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1(-) CD4(+) CD1d-dependent precursor stage. J. Exp. Med. 195:835-844.
39. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science. 296:553-555.
40. Hammond, K.J.L., L.D. Poulton, L.J. Palmisano, P.A. Silveira, D.I. Godfrey, and A.G. Baxter. 1998. Alpha/beta-T cell receptor (Tcr)(+)Cd4(-)Cd8(-) (Nkt) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (Nod)/Lt mice by the influence of interleukin (Il)-4 and/or Il-10. J. Exp. Med. 187:1047-1056.
41. Lehuen, A., O. Lantz, L. Beaudoin, V. Laloux, C. Carnaud, A. Bendelac, J.F. Bach, and R.C. Monteiro. 1998. Overexpression of natural killer T cells protects V-alpha-14-J-alpha-281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188:1831-1839.
42. Sonoda, K.H., D.E. Faunce, M. Taniguchi, M. Exley, S. Balk, and J. Stein-Streilein. 2001. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166:42-50.
43. Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M.J. Grusby, R.H. DeKruyff, and D.T. Umetsu. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9:582-588.
44. Campos, R.A., M. Szczepanik, A. Itakura, M. Akahira-Azuma, S. Sidobre, M. Kronenberg, and P.W. Askenase. 2003. Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J. Exp. Med. 198:1785-1796.
45. Kim, H.Y., H.J. Kim, H.S. Min, S. Kim, W.S. Park, S.H. Park, and D.H. Chung. 2005. NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor {beta}1 production. J. Exp. Med. 201:41-47.
46. Pal, E., T. Tabira, T. Kawano, M. Taniguchi, S. Miyake, and T. Yamamura. 2001. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells. J. Immunol. 166:662-668.
47. Lee, P.T., K. Benlagha, L. Teyton, and A. Bendelac. 2002. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195:637-641.
48. Lin, H., M. Nieda, and A.J. Nicol. 2004. Differential proliferative response of NKT cell subpopulations to in vitro stimulation in presence of different cytokines. Eur. J. Immunol. 34:2664-2671.
49. Smyth, M.J., K.Y.T. Thia, S.E.A. Street, D. MacGregor, D.I. Godfrey, and J.A. Trapani. 2000. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 192:755-760.